Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery

BACKGROUND: Perioperative chemotherapy is widely used in the treatment of oesophagogastric adenocarcinoma (OGAC) with a substantial survival benefit over surgery alone. However, the postoperative part of these regimens is given in less than half of patients, reflecting uncertainty among clinicians a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Saqib, Thomas, Betsan, Maynard, Nick, Park, Min Hae, Wahedally, Muhammad, Trudgill, Nigel, Crosby, Tom, Cromwell, David A., Underwood, Tim J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364695/
https://www.ncbi.nlm.nih.gov/pubmed/34910129
http://dx.doi.org/10.1093/bjs/znab427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364695/
https://www.ncbi.nlm.nih.gov/pubmed/34910129
http://dx.doi.org/10.1093/bjs/znab427

Ejemplares similares